Safety Considerations So far, BPC-157 has shown a strong safety profile in preclinical and limited human studies
Andersson, Emmanuel Shapira, Biochemical and clinical response to hydroxocobalamin versus cyanocobalamin treatment in patients with methylmalonic acidemia and homocystinuria (cblC), The Journal of Pediatrics, Volume 132, Issue 1, January 1998, Pages 121-124, ISSN 0022-3476, Okuda K, Yashima K, Kitazaki T, Takara I
BPC-157, used rigorously and within the limits of current evidence, is one of the more interesting tools available for addressing that decline at a mechanistic level
For example, you should avoid methylene blue if you are: Allergic to dyes Pregnant Taking medications rich in serotonin, including some analgesics and antidepressants
From vaccinations to medications, our range ensures your horse gets the care they deserve